CLSD Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space...

Stats
Dzisiejszy wolumen	182 482
Średni wolumen	379 738
Kapitalizacja rynkowa	99.39M
EPS	$0 ( 2024-05-09 )
Następna data zysków	( $-0.140 ) 2024-06-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.42
ATR14	$0.00900 (0.68%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-15	Yerxa Benjamin R	Buy	7 813	Common Stock
2024-04-18	Gibney Anthony S	Buy	93 290	Common Stock
2024-04-17	Gibney Anthony S	Buy	6 710	Common Stock
2024-04-15	Gibney Anthony S	Buy	45 000	Stock Option (right to buy)
2024-04-15	Gibney Anthony S	Buy	0

INSIDER POWER
67.80
Last 97 transactions
Buy: 5 503 181 \| Sell: 2 142 358

Wolumen Korelacja

Długi: -0.15 (neutral)

Krótki: 0.00 (neutral)

Signal:(50.988) Neutral

Clearside Biomedical Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Clearside Biomedical Inc Korelacja - Waluta/Towar

0.30
( neutral )

0.24
( neutral )

0.00
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.36
( neutral )

Clearside Biomedical Inc Finanse

Annual	2023
Przychody:	$8.23M
Zysk brutto:	$7.80M (94.87 %)
EPS:	$-0.530

FY	2023
Przychody:	$8.23M
Zysk brutto:	$7.80M (94.87 %)
EPS:	$-0.530

FY	2022
Przychody:	$1.33M
Zysk brutto:	$1.12M (84.63 %)
EPS:	$-0.570

FY	2021
Przychody:	$29.58M
Zysk brutto:	$29.58M (100.00 %)
EPS:	$0.00632

Financial Reports:

No articles found.

Clearside Biomedical Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.